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Abstract Acutely hospitalized older patients have an
increased risk of mortality, but at the moment of presen-
tation this risk is difficult to assess. Early identification of
patients at high risk might increase the awareness of the
physician, and enable tailored decision-making. Existing
screening instruments mainly use either geriatric factors or
severity of disease for prognostication. Predictive perfor-
mance of these instruments is moderate, which hampers
successive interventions. We conducted a retrospective
cohort study among all patients aged 70 years and over
who were acutely hospitalized in the Acute Medical Unit of
the Leiden University Medical Center, the Netherlands in
2012. We developed a prediction model for 90-day mor-
tality that combines vital signs and laboratory test results
reflecting severity of disease with geriatric factors, repre-
sented by comorbidities and number of medications.
Among 517 patients, 94 patients (18.2 %) died within
90 days after admission. Six predictors of mortality were
included in a model for mortality: oxygen saturation,
Charlson comorbidity index, thrombocytes, urea, C-reac-
tive protein and non-fasting glucose. The prediction model
performs satisfactorily with an 0.738 (0.667–0.798). Using
this model, 53 % of the patients in the highest risk decile
(N = 51) were deceased within 90 days. In conclusion, we
are able to predict 90-day mortality in acutely hospitalized
older patients using a model with directly available clinical
data describing disease severity and geriatric factors. After
further validation, such a model might be used in clinical
decision making in older patients.
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Introduction
Acute medical illness in older adults is a serious contrib-
utor to deterioration [1]. Within 90 days after hospitaliza-
tion, approximately 20 % will die [2, 3]. At the time of
admission it is difficult to determine who is at highest risk.
Visualizing the individual risk in an early phase of hospi-
talization might increase the awareness of the physician,
and enable tailored decision-making for the older patient,
although these interventions may not primarily be aimed at
reducing mortality. A high risk of mortality may reflect
overall vulnerability, which preventive interventions may
be aimed at, or conversely by usefully initiating palliative
care.
Screening models to identify older patients at risk of
mortality have been developed and evaluated [4, 5]. These
models mainly use either geriatric factors [5, 6] or severity
of disease [7, 8]. In these models, scores are assigned to the
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predictors, which lead to a total score with a cut-off point
for high-risk patients. Predictive performance using the
cut-off point shows relatively high sensitivity and low
specificity, resulting in high numbers of false positives. As
a consequence, large-scale implementation of these models
in daily care hampers successive interventions [6]. A
combination of routine clinical parameters, which reflect
the severity of disease, in combination with geriatric fac-
tors might improve accuracy and feasibility in daily care.
In the present retrospective cohort study we developed a
prediction model for 90-day mortality. We collected clin-
ical parameters of all hospitalized older patients of the
acute medical unit in 2012. Vital signs and laboratory
results reflect severity of disease with geriatric factors,
represented by comorbidities and number of medications.
We selected variables that are available in a very early
phase of hospitalization to enable in-hospital interventions.
Methods
Study design and setting
We performed a retrospective follow-up study among all
patients aged 70 years and over who were acutely hospi-
talized on the acute medical unit (AMU) of the Leiden
University Medical Center (LUMC), the Netherlands in
2012. Any following individual admission in the study
period, independent of the reason, and patients with pal-
liative care who were expected to die in a few days were
excluded. The AMU is a 13-bed ward particularly focussed
on acute admissions, mainly from the Emergency Depart-
ment. The population is characterized by hemodynamically
stable patients in the fields of internal medicine, surgery,
pulmonary diseases and gastroenterology. The medical
ethics committee of the LUMC waived the necessity for
formal approval of the present study, as all data were
available from standard care.
Predictors
We selected potential predictors of 90-day mortality from
the clinical parameters available at the moment of hospi-
talization on the AMU. These parameters reflect severity of
disease, including vital signs and laboratory results, and
underlying level of vulnerability, including comorbidity
and number of medications used at home. A predictor was
eligible if it fulfilled the following criteria: (1) it was
available in the medical records for retrospective analysis;
(2) available to the physician within 24 h after admission
and (3) assumed to have a relationship to the outcome
based on clinical reasoning by three medical doctors and
(4) was already being measured routinely to enhance in
future implementation, with a maximum of 15 % missing
values of each predictor. Multiple imputation techniques
were used to compute the missing predictors [9]. First
measured vital signs after hospitalization and first known
in-hospital laboratory results were extracted from the
electronic patient records (Chipsoft-EZIS, version 5.2,
2006–2014). Existing comorbidities and medications used
at home were obtained manually from the patient records,
where medication was reported as part of routine clinical
practice. Usually, the physician will first ask the patient at
the moment of hospitalization for comorbidities and med-
ication use. If necessary, the information will be verified
with the general practitioner or pharmacy.
Vital signs were assessed by the nurse directly after
admission and consisted of systolic and diastolic blood
pressure, heart rate, respiratory rate, oxygen saturation and
body temperature. First known in-hospital laboratory
results within 24 h after presentation were extracted and
consisted of: sodium (mmol/L), potassium (mmol/L), urea
(mmol/L), eGFR (estimated glomular filtration rate, cal-
culated by the modification of diet in renal disease
(MDRD) equation, ml/min/1.73 m2), leukocytes (9109/L),
thrombocytes (9109/L), C-reactive protein (mg/L), non-
fasted glucose (mmol/L) and haemoglobin (mmol/L).
Comorbidity was evaluated with the Charlson comorbidity
index (CCI). It incorporates weighted scores for 19 medical
conditions, increasing from 1 to 6 with severity. The CCI is
a frequently used instrument by researchers, and has been
validated to predict 1-year mortality [10, 11]. The number
of different medications at home was recorded according to
their pharmacological sub classification. Medications of the
same subgroup count as one drug, and combined medica-
tions of two different pharmacological sub-classifications
were considered as two different drugs. Topical and ‘as
required’ medications were excluded because of the unre-
liable registration rate of the physicians and the absence of
information whether the patient actually used it. If recorded
in the medical records, over-the-counter medications were
included when patients used it on regular base.
Outcome
The primary endpoint was mortality within 90 days after
hospital admission. Mortality dates were assessed from the
Dutch municipality records.
Coding predictors
We aimed to develop a model with a high positive pre-
dictive value (PPV) to enable targeted interventions, and
therefore the model should have high specificity. Because a
model based on a risk score derived from clinical cut-off
values is easier to implement in clinical practice than a
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model based on computations with continuous variables,
we started to dichotomize continuous predictors by using
the ranges of clinical reference categories. A stricter clin-
ically relevant cut-off point was chosen in cases when
specificity on 90-day mortality was lower than fifty per-
cent. However, dichotomizing may lead to loss of infor-
mation, reduction in power and uncertainly in defining the
optimal cutpoint [12]. In a sensitivity analysis, we repeated
the same analyses with preservation of continuous predic-
tors to compare discriminative performance.
Statistical/data analysis
Descriptive baseline characteristics were expressed in
percentages, means with standard deviations and medians
with interquartile ranges. A Kaplan–Meier curve was used
to show cumulative mortality of patients after admission.
Binary logistic regression techniques for both dichotomised
and continuous data were used for uni- and multivariable
analysis on mortality (no censoring occurred). The pre-
diction model was derived via backward elimination with
Akaike’s Information Criterion for candidate predictors.
With this technique the most significant predictors remain
in the model, while ‘‘noise’’ is reduced by eliminating
predictors that are not statistically significant. Discrimina-
tive performance of the different models was assessed with
the area under the receiver operating characteristic curve
(AUC).The model was internal validated with 500 boot-
strap samples, where we repeated the backward elimination
procedure. With this method internal validity is tested by
drawing 500 different population samples from the original
sample. The test reflects how robust the findings are when
slight changes are made to the population, and was pre-
sented with the internal validated AUC. The formula 1/
(1 ? exp(-linear predictor))was applied to determine the
individual risk on 90-day mortality [13]. Performance of
the final model is shown with the sensitivity, specificity,
positive predictive value (PPV), negative predictive value
(NPV), positive likelihood ratio and negative likelihood
ratio.
In clinical practice, cut-off points are often used, e.g., to
interpret laboratory results. In prediction dichotomizing
continuous predictors is arguable, because of a loss of
information [12]. When using cut-off points, laboratory
results just outside the reference range are considered the
same risk as more extreme results, which diminishes the
power of the model. In a sensitivity analyses we treated
predictors as continuous variables to compare discrimina-
tion. First outlying observations were truncated to 5 and
95 % by means of winsorization [13]. Second restricted
cubic spline techniques with three knots were applied to
continuous predictors in a binary regression model, and
discrimination was analysed by calculation the AUC. The
level of significance was set at P\ 0.05. Statistical anal-
yses were performed using IBM SPSS Statistics package
(version 20) and R version 3.1.1.
Results
In 2012, 606 older patients were acutely hospitalized to the
acute medical unit (AMU) of our hospital. By excluding 86
subsequent admissions and 3 moribund patients, a final
cohort of 517 patients was available for final analysis.
The baseline characteristics of the cohort are described
in Table 1. The mean age was 78.3 years, 269 (52.0 %)
patients were male, 467 (90.3 %) were admitted via the
Emergency Department and 367 (71.0 %) were primary
treated under the responsibility of one of the medical
specialities (internal medicine, surgery or pulmonary dis-
eases). Mean laboratory results were within the normal
range or slightly below or above these thresholds. The
median number of comorbidities was 2 (IQR 1-4), and
median number of medications used at home was 7 (IQR
4-11).
Supplemental Table 1 gives an overview of categories
of the dichotomization process. Missing values, up to 11 %
in thrombocytes, were imputed. Most reference ranges
reflect clinical normal ranges, except that we chose dif-
ferent rounded cut-offs for systolic blood pressure
(\200 mmHg), urea (\15.0 mmol/L) and c-reactive pro-
tein (CRP,\100 mg/L), leukocytes (\13 9 109/L), eGFR
([30 ml/min/1.73 m2) and haemoglobin ([6.5 mmol/L for
females and[7.5 mmol/L for males) to reflect more
specific measures of disease severity.
After 90 days, 94 patients (18.2 %) had died (supple-
mental Fig. 1). In Table 2, results of the univariate analy-
ses and the performance of all individual predictors are
shown. Oxygen saturation, heart rate, Charlson comorbid-
ity index (CCI), thrombocytes, urea, potassium and CRP
outside the reference range are statistically significantly
associated with 90-day mortality. In contrast, non-fasted
glucose and creatinine clearance outside the reference
range prove to have a protective effect. Age and gender
show no association with 90-day mortality. Best perfor-
mance of a single variable is the CCI. A score of 5 or
higher (N = 91) yields a positive predictive value (PPV) of
0.37 and area under the curve (AUC) of 0.61.
Results of the multivariable and final model are dis-
played in Table 3. A backward selection procedure results
in a model of six predictors including oxygen saturation,
CCI, thrombocytes, urea, CRP and non-fasted glucose. The
area under the curve (AUC) is 0.738 (95 %CI 0.967–0.798)
and decreases to 0.724 after internal validation.
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By applying the formula 1/(1 ? exp(-(-2.127
? 0.862 9 ‘saturation’ ? 1.201 9 ‘CCI’ ? 0.774 9
‘thrombocytes’ ? 0.706 9 ‘urea’ ? 0.588 9 ‘CRP’ ?
-0.791 9 ‘non-fasted glucose’ ))) the individual risk of
90-day mortality in acutely hospitalized older patients was
calculated. Figure 1 shows the calibration plot of the final
model. Over the whole range predicted probabilities are in
line with the observed, with more spread in the higher risk
groups. In Table 4 we calculated predictive performance of
the 30, 20 and 10 % patients at highest risk to provide
information about clinical usefulness. Positive likelihood
ratio’s range from 2.70 to 5.06. The positive predicting
value of the 51 patients (10 %) at highest risk is 0.53 and
implies that 53 % die within 90 days after admission.
As a sensitivity analysis we repeated analyses for the
multivariate and final model with continuous data. Accu-
racy is comparable in both multivariate and final model.
The AUC for continuous data is 0.771 (95 %CI
0.717–0.825) and after dichotomization 0.758 (95 %CI
0.702–0.815) in the multivariate model and 0.736 (95 %CI
0.677–0.795) and 0.738 (95 %CI 0.678–0.798) in the final
model (data not shown).
Discussion
In the present study, we developed a prediction model for
90-day mortality in acutely hospitalized older patients
using routinely collected clinical parameters describing
disease severity and geriatric factors. With this model we
are able to identify a high-risk group with an average 53 %
risk of mortality within 90 days after admission compared
to the baseline risk of 18.2 %.
We developed and internally validated a prediction
model for 90-day mortality in acutely hospitalized older
patients using six routinely collected clinical parameters
and with adding age and gender. Underlying vulnerability
of older patients is reflected in the Charlson comorbidity
index (CCI) and severity of disease in oxygen saturation,
thrombocytes, urea, C-reactive protein and non-fasted
glucose. CCI was developed to predict mortality in medical
patients [14], and was recently validated in acutely hospi-
talized older adults to predict both short- and long-term
mortality [11]. Models using vital signs have also been
previously studied to predict mortality. The acute physi-
ology and chronic health evaluation (APACHE II) is a
severity of disease classification system developed to pre-
dict in-hospital mortality in intensive care unit patients of
all ages [15]. The APACHE II comprises a combination of
vital parameters and different laboratory results. The sim-
ple clinical score (SCS) is a prediction model for 30-day
mortality in acutely admitted patients [8], and consists of
16 parameters, including vital parameters and presentation
signs such as new stroke, coma and abnormal ECG. The
Modified Early Warning Score (MEWS) was originally
designed for the ED setting to identify medical patients at
risk of catastrophic deterioration, and was subsequently
validated for prediction of in-hospital mortality in hospi-
talized patients [7]. The MEWS incorporates five vital
signs: systolic blood pressure, pulse rate, respiratory rate,
body temperature and level of consciousness. The afore-
mentioned models are well validated and are used in
practice, but share the disadvantage that prognostic
Table 1 Baseline characteristics of the study population
Characteristics N = 517
Male, n (%) 269 (52.0 %)
Age, mean (SD) 78.3 (6.2)
Admitted from, n (%)
Emergency department 467 (90.3 % )
Outpatient clinic 42 (8.1 %)
Other 8 (1.6 %)
Clinical specialism, n (%)
Internal medicine 367 (71.0 %)
Surgery 74 (14.3 %)
Pulmonary diseases 34 (6.6 %)
Other 42 (8.1 %)
Severity of disease
Vital parametersa
Oxygen saturation (%), median (IQR) 98 (96–99)
Systolic blood pressure (mm Hg), mean (SD) 132.9 (23.3)
Diastolic blood pressure (mm Hg), mean (SD) 67.6 (13.9)
Heart rate (/min), mean (SD) 83.2 (16.6)
Laboratory results
Sodium (mmol/L), mean (SD) 138.6 (5.4)
Potassium (mmol/L), mean (SD) 4.3 (0.7)
Urea (mmol/L), median (IQR) 9.4 (6.7–14.7)
eGFR (ml/min/1.73 m2), mean (SD) 64.8 (34.5)
Leukocytes (9109/L), mean (SD) 11.3 (5.3)
Thrombocytes (9109/L), mean (SD) 241 (119)
C-reactive protein (mg/L), median (IQR) 41 (8–110)
Non-fasted glucose (mmol/L), mean (SD) 8.1 (3.6)
Haemoglobin (mmol/L), mean (SD) 7.6 (1.5)
Geriatric factors
Charlson comorbidity index, median (IQR)b 2 (1–4)
Number of medications, median (IQR) 7 (4–11)
eGFR estimated glomerular filtration rate; SD standard deviation,
IQR inter quartile range
a Respiratory rate and body temperature were excluded from further
analysis, because the measurement was not performed or noted
in[50 %
b Incorporates weighted scores for 19 medical conditions, higher
scores indicating worse history of disease
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accuracy among older patients is modest with relatively
low positive predicting values. An explanation might be the
use of (bed-side) scores with a cut-off point, instead of
using individual risk scores. Or it could be the use of either
severity of disease characteristics or geriatric factors in the
prediction model. Another explanation could be that pre-
diction models were developed in a more severely ill
population of all ages, with the consequence that results
were neither representative nor tailored for these older
patients [16, 17]. Unexpected findings is the positiveness of
abnormal thrombocytes and urea. To our knowledge, these
measurements are not used in other comparable prediction
models. Validity of this might be explained by the possible
over-representation of patients with low thrombocytes
being treated with chemotherapy or high urea caused by
dehydration or kidney failure. Another unexpected finding
is the protective value of creatinine clearance\30 (ml/min/
1.73m2) on 90-day mortality (OR 0.48, 95 % CI 0.28–0.84)
in the univariate analysis. A possible explanation could be
that the hospital is a centre for patients requiring dialysis
and kidney transplantation. These patient groups are hos-
pitalized more readily, with possible less severe acute
medical conditions. However, in the multivariate model
and by using creatinine clearance as a continuous variable
the association is lost, indicating that it could also be
caused by outliers. Taken together, we show that combin-
ing parameters reflecting severity of disease and geriatric
factors results in an prediction model capable of predicting
90-day mortality in acutely hospitalized older patients.
We made several choices in developing our model, in
order to be ready for clinical implementation. First, we
used routinely available clinical parameters. Candidate
predictors were known within 24 h after admission. Sec-
ond, we used a formula instead of a bed-side scorecard.
Health care professionals do not have to calculate risks by
hand, preferable the formula should be integrated in the
electronic patients records or be available in a smartphone
application. By providing an individual risk for each
patient, the consequences of the screening can vary.
Depending on the local resource availability a hospital can
implement interventions. As an example, comprehensive
geriatric assessment could be performed in all older
patients with a risk of 30 % or higher, which includes extra
attention for patient preferences, treatment goals and pos-
sible palliative trajectories. In another hospital the advice
for the treating physician could be to take into account both
the individual risk score and the condition of the patient in
decision making, without standardized interventions.
Third, we aimed for a model with a high specificity,
resulting in a high positive predictive value (PPV) in
relation with the baseline risk. The PPV will give the
clinician a robust feeling and may therefore be more rel-
evant than a high AUC with modest predictive values. The
identification senior at risk (ISAR) is also a prediction tool,
Table 2 Univariate
associations and the
performance of single predictors
of 90-day mortality in acutely
hospitalized older patients
Univariate Performance
Number (%)a OR 95 % CI Sens Spec PPV NPV AUC
Age (per 5 years increase) – 1.05 0.88–1.25 – – – – 0.52
Male 269 (52) 1.38 0.88–2.17 0.59 0.49 0.20 0.84 0.54
Saturation 108 (21) 2.21 1.35–3.63 0.33 0.82 0.29 0.85 0.57
Systolic blood pressure 39 (8) 1.39 0.64–3.03 0.10 0.93 0.23 0.82 0.51
Diastolic blood pressure 206 (40) 1.21 0.77–1.90 0.44 0.61 0.20 0.83 0.52
Heart rate 136 (26) 1.68 1.04–2.71 0.35 0.76 0.24 0.84 0.55
Charlson comorbidity indexb 91 (18) 3.64 2.20–6.03 0.36 0.87 0.37 0.86 0.61
Number of medications 153 (30) 1.53 0.96–2.45 0.37 0.72 0.23 0.84 0.55
Thrombocytes 139 (27) 2.16 1.35–3.46 0.40 0.76 0.27 0.85 0.58
Urea 126 (24) 2.44 1.52–3.92 0.39 0.79 0.29 0.85 0.59
Leukocytes 169 (33) 1.43 0.90–2.27 0.39 0.69 0.22 0.84 0.54
Sodium 162 (31) 1.16 0.72–1.87 0.34 0.69 0.20 0.83 0.52
Potassium 134 (26) 1.73 1.07–2.78 0.35 0.76 0.25 0.84 0.56
Haemoglobin 161 (31) 1.57 0.98–2.49 0.39 0.71 0.23 0.84 0.55
C-reactive protein 141 (27) 1.77 1.11–2.85 0.37 0.75 0.25 0.84 0.56
Non-fasted glucose 361 (70) 0.51 0.32–0.81 0.43 0.73 0.26 0.85 0.58
eGFR 76 (15) 0.48 0.28–0.84 0.23 0.87 0.29 0.84 0.55
eGFR estimated glomerular filtration rate
a Number represents number of patients outside reference category
b Incorporates weighted scores for 19 medical conditions, higher scores indicating worse history of disease
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originally developed to identify older patients in the ED at
increased risk of adverse health outcomes, a composite
outcome of functional decline and mortality [18]. The
ISAR is a widely used tool in the ED [19], and validated
among 667 acute hospitalized older adults for prediction of
adverse outcomes, including mortality. After 90 days of
follow-up 5 % had died, with 6 % of the patients assigned
high risk deceased within 90 days, indicating a low posi-
tive predictive value. The negative predictive value (NPV)
for 90-day mortality was 0.97, which means that 97 % of
the patients not at risk were still alive after 90 days. These
results imply that the ISAR in this setting is more suit-
able to rule out patients at high risk, whereas our model is
tailored to identify older patients at high risk for mortality
with a PPV of 0.53 in the highest risk group. Identifying of
patients at low risk (‘‘rule-out’’) may be a very sensible
strategy in its own right. However, our aim is to specifi-
cally identify patients at the highest risk because these are
the patients we want to follow-up with intervention, and we
want to aim our limited clinical resources to only those at
the highest risk.
Our study has several limitations. First, we studied retro-
spective data, and therefore the number of available predictors
Table 3 Multivariate and final
model of predictors of 90-day
mortality in acute hospitalized
older patients
Multivariate Final model
OR 95 % CI b OR 95 % CI P value
Age (per 5 years) 1.20 0.97–1.47
Male 1.34 0.79–2.25
Saturation 2.32 1.34–4.03 0.862 2.37 1.39–4.05 0.002
Systolic blood pressure 0.96 0.38–2.45
Diastolic blood pressure 1.02 0.60–1.72
Heart rate 1.58 0.93–2.70
Charlson comorbidity indexa 3.45 1.95–6.10 1.201 3.32 1.94–5.70 \0.001
Number of drugs 1.43 0.79–2.58
Thrombocytes 2.10 1.24–3.56 0.774 2.17 1.30–3.62 0.003
Urea 1.90 0.98–3.66 0.706 2.03 1.21–3.41 0.008
Leukocytes 1.24 0.73–2.11
Sodium 1.08 0.64–1.82
Potassium 1.38 0.80–2.40
Haemoglobin 1.06 0.62–1.81
C-reactive protein 1.65 0.96–2.81 0.588 1.80 1.08–2.99 0.023
Non-fasted glucose 0.44 0.26–0.73 -0.791 0.45 0.28–0.75 0.002
eGFR 1.24 0.57–2.69
Intercept -2.127
AUC (95 % CI) 0.738 (0.678–0.798)
Internal validated AUC
0.724
eGFR estimated glomerular filtration rate, AUC area under curve, Internal validated AUC the obtained
AUC after bootstrapping with backward selection
a Incorporates weighted scores for 19 medical conditions, higher scores indicating worse history of disease
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Fig. 1 Comparison of observed and predicted 90-day mortality for
acutely hospitalized patients into 10 equal groups
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and related outcomes were limited. Ideally, predictors such as
cognition, functional status and outcomes such as functional
decline, and readmissions should also be used, but these were
not available in this retrospective study. Second, the fact that
we found someunexpected results further stresses the need for
external validation, as it is impossible to distinguish whether
these findings are specific to our cohort, chance finding or
reproducible in other cohorts. Strengths of the present study
are that our prediction model is based on routinely measured
and directly available candidate predictors. This enhances
convenient future implementation in an early phase of pre-
sentation. We used clinical cut-off points to reflect clinical
practice and relate to the awareness of the physician. From a
methodological point of view using continuous variables is
preferable, but is harder to relate to clinical practice. Never-
theless, accuracy of our model is equally well when dichot-
omized or with continuous variables. Another strength is the
high specificity of the developed model. This specificity
ensures the development of interventions that are aimed at a
relatively small group of patients at high risk of a negative
event. Such tools are of importance in the emergency medi-
cine setting, allowing physicians in EDs and Acute Wards to
make informed decisions on diagnostic and therapeutic
strategies in older patients and the implementation of mea-
sures to prevent poor outcome.
In conclusion, we developed a prediction model on
90-day mortality in acutely hospitalized older patients. We
used a combination of predictors containing information
about severity of disease and geriatric factors and calcu-
lated individual risk scores. Currently, we are conducting a
large multicentre prospective follow-up study among
acutely presenting older patients in both the ED and wards,
including more candidate predictors and outcomes.
Acknowledgments The authors acknowledge the contribution of
Mary Ann Etty for the data extraction from patient records.
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflict
of interest.
Statement of human and animals rights The procedures followed
were in accordance with the standards of the medical ethics com-
mittee and with the Helsinki Declaration of 1975, as revised in 2008.
Informed consent This study does not require informed consent.
Funding The Institute for Evidence-Based Medicine in Old Age
(IEMO) is funded by the Dutch Ministry of Health and Welfare and
supported by ZonMW (project number 62700.3002).
Author contributions J de Gelder, J.A. Lucke, N. Heim, A.J.M.
Craen, B. de Groot, A.J. Fogteloo, G.J. Blauw, S.P. Mooijaart: con-
ception and design of the study. J. de Gelder, S.D. Lourens: acqui-
sition of data. J. de Gelder, E.W. Steyerberg, S. P. Mooijaart:
Analysis and interpretation of data. J. de Gelder and S. P. Mooijaart:
Drafting the article. J. A. Lucke, N. Heim, S. D. Lourens, A. J. M.
Craen, B. de Groot, A. J. Fogteloo, E. W. Steyerberg, G. J. Blauw:
Revision for important intellectual content. All authors gave final
approval of the current version of the article.
Sponsor’s role The sponsor had no role in the study.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://crea
tivecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
References
1. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K (2013)
Frailty in elderly people. Lancet 381(9868):752–762
2. Covinsky KE, Palmer RM, Fortinsky RH, Counsell SR, Stewart
AL, Kresevic D, Burant CJ, Landefeld CS (2003) Loss of inde-
pendence in activities of daily living in older adults hospitalized
with medical illnesses: increased vulnerability with age. J Am
Geriatr Soc 51(4):451–458
3. Smolin B, Levy Y, Sabbach-Cohen E, Levi L, Mashiach T (2015)
Predicting mortality of elderly patients acutely admitted to the
Department of Internal Medicine. Int J Clin Pract 69(4):501–508
4. Campbell SE, Seymour DG, Primrose WR, Project A (2004) A
systematic literature review of factors affecting outcome in older
medical patients admitted to hospital. Age Ageing 33(2):110–115
5. Wou F, Gladman JR, Bradshaw L, Franklin M, Edmans J, Conroy
SP (2013) The predictive properties of frailty-rating scales in the
acute medical unit. Age Ageing 42(6):776–781
6. Edmans J, Bradshaw L, Gladman JR, Franklin M, Berdunov V,
Elliott R, Conroy SP (2013) The Identification of Seniors at Risk
(ISAR) score to predict clinical outcomes and health service costs
in older people discharged from UK acute medical units. Age
Ageing 42(6):747–753
7. Cei M, Bartolomei C, Mumoli N (2009) In-hospital mortality and
morbidity of elderly medical patients can be predicted at
Table 4 Performance of
predicted high risk deciles in
older hospitalized patients
Number of
patients
Sens Spec PPV NPV LR? LR-
30 % high risk 160 0.64 0.76 0.38 0.90 2.70 0.47
20 % high risk 106 0.50 0.86 0.44 0.89 3.58 0.58
10 % high risk 51 0.29 0.94 0.53 0.86 5.06 0.76
Sens sensitivity, Spec specificity, PPV positive predicting value, NPV negative predicting value,
LR? positive likelihood ratio, LR- negative likelihood ratio
Intern Emerg Med (2016) 11:587–594 593
123
admission by the modified early warning score: a prospective
study. Int J Clin Pract 63(4):591–595
8. Kellett J, Deane B (2006) The Simple Clinical Score predicts
mortality for 30 days after admission to an acute medical unit.
QJM 99(11):771–781
9. Janssen KJ, Vergouwe Y, Donders AR, Harrell FE Jr, Chen Q,
Grobbee DE, Moons KG (2009) Dealing with missing predictor
values when applying clinical prediction models. Clin Chem
55(5):994–1001
10. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new
method of classifying prognostic comorbidity in longitudinal
studies: development and validation. J Chronic Dis
40(5):373–383
11. Frenkel WJ, Jongerius EJ, Mandjes-van Uitert MJ, van Munster
BC, de Rooij SE (2014) Validation of the Charlson comorbidity
index in acutely hospitalized elderly adults: a prospective cohort
study. J Am Geriatr Soc 62(2):342–346
12. Royston P, Altman DG, Sauerbrei W (2006) Dichotomizing
continuous predictors in multiple regression: a bad idea. Stat Med
25(1):127–141
13. Steyerberg EW (2009) Clinical prediction models: a practical
approach to development, validation, and updating. Springer,
New York
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new
method of classifying prognostic comorbidity in longitudinal
studies: development and validation. J Chronic Dis 40(5):373–383
15. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985)
APACHE II: a severity of disease classification system. Crit Care
Med 13(10):818–829
16. Mooijaart SP, Broekhuizen K, Trompet S, de Craen AJ,
Gussekloo J, Oleksik A, van Heemst D, Blauw GJ, Muller M
(2015) Evidence-based medicine in older patients: how can we do
better? Netherlands J Med 73(5):211–218
17. Broekhuizen K, Pothof A, de Craen AJ, Mooijaart SP (2015)
Characteristics of randomized controlled trials designed for
elderly: a systematic review. PLoS One 10(5):e0126709
18. McCusker J, Bellavance F, Cardin S, Trepanier S, Verdon J,
Ardman O (1999) Detection of older people at increased risk of
adverse health outcomes after an emergency visit: the ISAR
screening tool. J Am Geriatr Soc 47(10):1229–1237
19. Yao JL, Fang J, Lou QQ, Anderson RM (2015) A systematic
review of the identification of seniors at risk (ISAR) tool for the
prediction of adverse outcome in elderly patients seen in the
emergency department. Int J Clin Exp Med 8(4):4778–4786
594 Intern Emerg Med (2016) 11:587–594
123
